Balanced news tone
News Sentiment
FBIOP sentiment intelligence
Fortress Biotech Inc Pref Series A news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
80/100 classification confidence.
directly relevant articles
high-authority source matches
+5.3% over one week, +7.1% over four weeks, trend active, and materially above fair value.
Precision Trading with Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) Risk Zones
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Journey Medical (DERM) Stock Draws Fresh Price Target Split After Fortress Valuation Changes
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 25 Jun 2026 04:29
- Source
- Simply Wall St.
Fortress Biotech (NASDAQ: FBIO) CFO receives 400,000 RSU award
Fortress Biotech's CFO, Jin David, was granted 400,000 restricted stock units (RSUs) as equity compensation, increasing his total holdings to 1,651,571 shares. These RSUs will vest in four equal annual installments, with the first vesting on January 5, 2027, contingent on his con
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 02:42
- Source
- Stock Titan
Enterprise value to revenue forward of Fortress Biotech, Inc. – NASDAQ:FBIO
The article provides a financial snippet for Fortress Biotech, Inc. (NASDAQ: FBIO), focusing on its enterprise value to revenue forward metric. It displays the current value, change, and percentage change for this financial indicator, noting that the market is closed without rece
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Jun 2026 00:42
- Source
- TradingView
Fortress Biotech Preferred Stock (FBIOP) Holds Steady Near Midpoint of Recent Range - PCR Moving Average
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 18:44
- Source
- dars.gov.et
Fortress Biotech Preferred Stock (FBIOP) Pulls Back 2.3% as Shares Approach Key Support - Positive Gamma
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 08 Jun 2026 07:00
- Source
- dars.gov.et
Fortress Biotech Preferred Stock (FBIOP) Faces Resistance, Slides 2.3% in Quiet Session - Early Entry Signals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 07:00
- Source
- dars.gov.et
Fortress Biotech Preferred Stock (FBIOP) Faces Resistance, Slides 2.3% in Quiet Session - Quote Data
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 07:00
- Source
- dars.gov.et
Fortress Biotech: Is It Time To Pay The Deferred Preferred Stock Dividends? (FBIO)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- Seeking Alpha
Fortress Biotech Preferred (FBIOP) Gains 1.21% as Income Seekers Eye 9.375% Yield - Cumulative Volume
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- po-news-eg.net
Fortress Biotech Preferred (FBIOP) Gains 1.21% as Income Seekers Eye 9.375% Yield - Standard Deviation
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- dars.gov.et
Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2026 12:30
- Source
- GlobeNewswire
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Fortress Biotech: Q1 Earnings Snapshot
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 20:50
- Source
- Associated Press
Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 20:10
- Source
- GlobeNewswire
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Feb 2026 08:00
- Source
- Barron's
Fortress Biotech: The PRV Catalyst That Could Reprice This Microcap
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Feb 2026 08:00
- Source
- Seeking Alpha